Better understanding of respiratory physiology and progress in ventila
tor technology have contributed to improved mortality and morbidity of
premature neonates. Yet, pulmonary complications remain high and ther
e is no consensus about the optimal regimen of mechanical ventilation.
We report our satisfactory 10-year experience with conventional mecha
nical ventilation based on a relatively low incidence of pulmonary bar
otrauma. The introduction of surfactant has facilitated the ventilator
y management of premature neonates since the usually rapid improvement
of the acute lung disease after surfactant administration allows for
earlier weaning from mechanical ventilation. However, our own results
and the results from most surfactant studies show no significant reduc
tion in the incidence of intraventricular haemorrhage. Thus, though me
chanical ventilation and surfactant administration are milestones in n
eonatal therapeutic management, the problems encountered in very low b
irth weight neonates both with respect to mortality and morbidity have
not been generally solved and underline the role of optimal perinatal
management.